26 November 2025 : Database Analysis
Long-Term Outcomes of Anticoagulation Monotherapy Versus Combination Therapy in Atrial Fibrillation Patients with Complex Coronary Artery Disease
Wei-Chieh Lee ABCDG 1,2*, Wei-Ting Chang F 1,2, Chon-Seng Hong B 2, Chih-Hsien Lin B 2, Chun-Yen Chiang
B 2, Pei-Chieh Huang B 2, Zhih-Cherng Chen BF 1,2, Jhih-Yuan Shih B 1,2, Hsiu-Yu Fang EF 3,4
DOI: 10.12659/MSM.950655
Med Sci Monit 2025; 31:e950655
Figure 3 Subgroup analysis of revascularization incidence by clinical and anatomical characteristicsFigure illustrates revascularization incidence across clinical and anatomical subgroups. In the comparison of subgroups with SYNTAX score <33 (group 1 vs group 2, 16.7% vs 52.6%, P=0.021), no left main disease (group 1 vs group 2, 16.7% vs 50.0%, P=0.041), HAS-BLED score ≥3 (group 1 vs group 2, 0% vs 66.7%, P=0.021), and ACS (group 1 vs group 2, 5.0% vs 66.7%, P<0.001), significant higher incidences presented in group 2. In the comparison of subgroups with SYNTAX score ≥33 (group 1 vs group 2, 0% vs 40.0%, P=0.128), left main disease (group 1 vs group 2, 0% vs 50.0%, P=0.055), HAS-BLED score <3 (group 1 vs group 2, 16.0% vs 44.4%, P=0.082), and stable angina (group 1 vs group 2, 25.0% vs 33.3%, P=1.000), did not differ between the 2 groups.